XML 159 R131.htm IDEA: XBRL DOCUMENT v3.25.0.1
Fair Value Measurement - Financial Assets and Liabilities Accounted for at Fair Value on Recurring Basis (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2024
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale debt securities $ 289,307 $ 313,991
Investments under executive deferred compensation plan 33,564 38,243
Private equity securities 168,928 17,910
Private equity securities measured at net asset value 4,536 4,472
Derivative financial instruments, assets 17,829 4,347
Obligations under executive deferred compensation plan 33,564 38,243
Derivative financial instruments, liabilities 5,752 11,352
Change in fair value 4,555  
Quoted Prices in Active Markets for Identical Items (Level 1)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale debt securities 0 0
Investments under executive deferred compensation plan 33,564 38,243
Private equity securities 168,928 17,910
Private equity securities measured at net asset value 0 0
Derivative financial instruments, assets 0 0
Obligations under executive deferred compensation plan 33,564 38,243
Derivative financial instruments, liabilities 0 0
Quoted Prices in Active Markets for Similar Items (Level 2)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale debt securities 0 0
Investments under executive deferred compensation plan 0 0
Private equity securities 0 0
Private equity securities measured at net asset value 0 0
Derivative financial instruments, assets 17,829 4,347
Obligations under executive deferred compensation plan 0 0
Derivative financial instruments, liabilities 5,752 11,352
Unobservable Inputs (Level 3)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale debt securities 289,307 313,991
Investments under executive deferred compensation plan 0 0
Private equity securities 0 0
Private equity securities measured at net asset value 0 0
Derivative financial instruments, assets 0 0
Obligations under executive deferred compensation plan 0 0
Derivative financial instruments, liabilities $ 0 $ 0